CAROLINE SAUERS: Open Payments
NPI 1003279258 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,600 in 160 payments from 36 companies in 2025. Trend: 2023 $3,634 · 2024 $4,107 · 2025 $3,600
Food & beverage: $3,600
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $500 |
| UCB, Inc. | 17 | $351 |
| TG Therapeutics, Inc. | 6 | $271 |
| Neurelis, Inc. | 9 | $209 |
| Novartis Pharmaceuticals Corporation | 11 | $205 |
| Lilly USA, LLC | 6 | $198 |
| Lundbeck LLC | 9 | $166 |
| ARGENX US, INC. | 6 | $152 |
| Averitas Pharma Inc. | 5 | $130 |
| Eisai Inc. | 2 | $120 |
Products named: BRIUMVI, VALTOCO, KESIMPTA, KISUNLA, BOTOX, VYVGART HYTRULO, Rystiggo, UBRELVY.
Industry payments across GA — which companies pay providers there.
